{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:20:26Z","timestamp":1787624426912,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This study is mainly supported by the Applied Basic Research Project of Southwest Medical University","award":["2025JC050"],"award-info":[{"award-number":["2025JC050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00210-026-05385-8","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:20:23Z","timestamp":1778901623000},"page":"17017-17041","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative multi-omics analysis identifies a core ferroptosis signature and validates resveratrol as a novel inducer in pancreatic cancer"],"prefix":"10.1007","volume":"399","author":[{"given":"Wenji","family":"Diao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"key":"5385_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"MA Badgley","year":"2020","unstructured":"Badgley MA, Kremer DM, Maurer HC, DelGiorno KE, Lee HJ, Purohit V, Sagalovskiy IR, Ma A, Kapilian J, Firl CEM, Decker AR, Sastra SA, Palermo CF, Andrade LR, Sajjakulnukit P, Zhang L, Tolstyka ZP, Hirschhorn T, Lamb C, Liu T, Gu W, Seeley ES, Stone E, Georgiou G, Manor U, Iuga A, Wahl GM, Stockwell BR, Lyssiotis CA, Olive KP (2020) Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science 368:85\u201389","journal-title":"Science"},{"key":"5385_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217699","volume":"622","author":"K Br\u00e4utigam","year":"2025","unstructured":"Br\u00e4utigam K, Skok K, Szymonski K, Rift CV, Karamitopoulou E (2025) Tumor immune microenvironment in pancreatic ductal adenocarcinoma revisited - exploring the \u201cspace.\u201d Cancer Lett 622","journal-title":"Cancer Lett"},{"key":"5385_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156538","volume":"139","author":"W Cai","year":"2025","unstructured":"Cai W, Li Z, Wang W, Liu S, Li Y, Sun X, Sutton R, Deng L, Liu T, Xia Q, Huang W (2025) Resveratrol in animal models of pancreatitis and pancreatic cancer: a systematic review with machine learning. Phytomedicine 139","journal-title":"Phytomedicine"},{"key":"5385_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00535-021-01800-4","volume":"56","author":"A Cannon","year":"2021","unstructured":"Cannon A, Thompson CM, Bhatia R, Armstrong KA, Solheim JC, Kumar S, Batra SK (2021) Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma. J Gastroenterol 56:689\u2013703","journal-title":"J Gastroenterol"},{"key":"5385_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1132424","volume":"13","author":"J Chen","year":"2023","unstructured":"Chen J, Liu Z, Wu Z, Li W, Tan X (2023) Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer. Front Oncol 13","journal-title":"Front Oncol"},{"key":"5385_CR6","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1080\/15548627.2020.1714209","volume":"16","author":"E Dai","year":"2020","unstructured":"Dai E, Han L, Liu J, Xie Y, Kroemer G, Klionsky DJ, Zeh HJ, Kang R, Wang J, Tang D (2020) Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy 16:2069\u20132083","journal-title":"Autophagy"},{"key":"5385_CR7","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, Teinor JA, Belleau P, Biffi G, Lucito MS, Sivajothi S, Armstrong TD, Engle DD, Yu KH, Hao Y, Wolfgang CL, Park Y, Preall J, Jaffee EM, Califano A, Robson P, Tuveson DA (2019) Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov 9:1102\u20131123","journal-title":"Cancer Discov"},{"key":"5385_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1438935","volume":"15","author":"L Jiang","year":"2024","unstructured":"Jiang L, Liu J, Zhang S, Jiang C, Huang J, Chen H, Zhou X, Fu Y, Yang Z, Wang R, Yang G, Chi H, Li B (2024) Role of glycosylation-related gene MGAT1 in pancreatic ductal adenocarcinoma. Front Immunol 15","journal-title":"Front Immunol"},{"key":"5385_CR9","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1016\/j.ymthe.2025.05.037","volume":"33","author":"H Jiang","year":"2025","unstructured":"Jiang H, Satoh Y, Yamamura R, Ooshio T, Luo Y, Hai H, Otsuka T, Hata S, Sato R, Hirata T, Osawa T, Goda K, Sonoshita M (2025) Inhibition of NAD-GPx4 axis and MEK triggers ferroptosis to suppress pancreatic ductal adenocarcinoma. Mol Ther 33:4618\u20134635","journal-title":"Mol Ther"},{"key":"5385_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126619","author":"HS Kantheti","year":"2024","unstructured":"Kantheti HS, Hale MA, Pal Choudhuri S, Huang H, Wang XD, Zolghadri Y, Innamorati G, Manikonda SPR, Reddy N, Reddy S, Kollipara RK, Lumani V, Girard L, Bezrukov Y, Demenkov P, MacDonald RJ, Brekken RA, Yu Y, Wilkie TM (2024) Diagnostic and prognostic markers for pancreatitis and pancreatic ductal adenocarcinoma. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25126619","journal-title":"Int J Mol Sci"},{"key":"5385_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107370","volume":"165","author":"Q Li","year":"2023","unstructured":"Li Q, Liu H, Jin Y, Yu Y, Wang Y, Wu D, Guo Y, Xi L, Ye D, Pan Y, Zhang X, Li J (2023) Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes. Comput Biol Med 165","journal-title":"Comput Biol Med"},{"key":"5385_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308208","volume":"11","author":"G Li","year":"2024","unstructured":"Li G, Liao C, Chen J, Wang Z, Zhu S, Lai J, Li Q, Chen Y, Wu D, Li J, Huang Y, Tian Y, Chen Y, Chen S (2024) Targeting the MCP-GPX4\/HMGB1 axis for effectively triggering immunogenic ferroptosis in pancreatic ductal adenocarcinoma. Adv Sci (Weinh) 11","journal-title":"Adv Sci (Weinh)"},{"key":"5385_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-024-04395-3","volume":"24","author":"C Mao","year":"2024","unstructured":"Mao C, Gong L, Kang W (2024) Effect and mechanism of resveratrol on ferroptosis mediated by p53\/SLC7A11 in oral squamous cell carcinoma. BMC Oral Health 24","journal-title":"BMC Oral Health"},{"key":"5385_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1473939","volume":"15","author":"L Peng","year":"2024","unstructured":"Peng L, Hu XZ, Liu ZQ, Liu WK, Huang Q, Wen Y (2024a) Therapeutic potential of resveratrol through ferroptosis modulation: insights and future directions in disease therapeutics. Front Pharmacol 15","journal-title":"Front Pharmacol"},{"key":"5385_CR15","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.3748\/wjg.v30.i19.2575","volume":"30","author":"T Peng","year":"2024","unstructured":"Peng T, Sun F, Yang JC, Cai MH, Huai MX, Pan JX, Zhang FY, Xu LM (2024b) Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma. World J Gastroenterol 30:2575\u20132602","journal-title":"World J Gastroenterol"},{"key":"5385_CR16","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2018.08.033","volume":"155","author":"F Puleo","year":"2018","unstructured":"Puleo F, Nicolle R, Blum Y, Cros J, Marisa L, Demetter P, Quertinmont E, Svrcek M, Elarouci N, Iovanna J, Franchimont D, Verset L, Galdon MG, Devi\u00e8re J, de Reyni\u00e8s A, Laurent-Puig P, Van Laethem JL, Bachet JB, Mar\u00e9chal R (2018) Stratification of pancreatic ductal adenocarcinomas based on tumor and microenvironment features. Gastroenterology 155:1999-2013.e1993","journal-title":"Gastroenterology"},{"key":"5385_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100960","volume":"68","author":"R Qi","year":"2023","unstructured":"Qi R, Bai Y, Li K, Liu N, Xu Y, Dal E, Wang Y, Lin R, Wang H, Liu Z, Li X, Wang X, Shi B (2023) Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resist Updat 68","journal-title":"Drug Resist Updat"},{"key":"5385_CR18","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1007\/s11010-025-05228-9","volume":"480","author":"Q Qiu","year":"2025","unstructured":"Qiu Q, Sun Q, Yang J, Yuan Q, Wang P, Liu Q, Cui Z, Ma X, Li M (2025) The molecular mechanism by which CTSB degrades FPN to disrupt macrophage iron homeostasis and promote the progression of atherosclerosis. Mol Cell Biochem 480:3889\u20133906","journal-title":"Mol Cell Biochem"},{"key":"5385_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102324","volume":"53","author":"G Rademaker","year":"2022","unstructured":"Rademaker G, Boumahd Y, Peiffer R, Anania S, Wissocq T, Li\u00e9geois M, Luis G, Sounni NE, Agirman F, Maloujahmoum N, De Tullio P, Thiry M, Bellahc\u00e8ne A, Castronovo V, Peulen O (2022) Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells. Redox Biol 53","journal-title":"Redox Biol"},{"key":"5385_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101928","volume":"6","author":"X Shen","year":"2025","unstructured":"Shen X, Chen Y, Tang Y, Lu P, Liu M, Mao T, Weng Y, Yu F, Liu Y, Tang Y, Wang L, Niu N, Xue J (2025) Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis. Cell Rep Med 6","journal-title":"Cell Rep Med"},{"key":"5385_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02803-w","volume":"16","author":"Z Tian","year":"2025","unstructured":"Tian Z, Liu Q, Luo J, Ning N, Qu J (2025) The role of HSPB1 in modulating ferroptosis in pancreatic cancer via the TP53\/SLC7A11\/GPX4 axis. Discov Oncol 16","journal-title":"Discov Oncol"},{"key":"5385_CR22","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.surg.2023.12.019","volume":"175","author":"A Tuerhong","year":"2024","unstructured":"Tuerhong A, Xu J, Wang W, Shi S, Meng Q, Hua J, Liu J, Zhang B, Yu X, Liang C (2024) CPT1B maintains redox homeostasis and inhibits ferroptosis to induce Gemcitabine resistance via the KEAP1\/NRF2 axis in pancreatic cancer. Surgery 175:1264\u20131275","journal-title":"Surgery"},{"key":"5385_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.mrrev.2012.04.002","volume":"751","author":"U Weyemi","year":"2012","unstructured":"Weyemi U, Dupuy C (2012) The emerging role of ROS-generating NADPH oxidase NOX4 in DNA-damage responses. Mutat Res 751:77\u201381","journal-title":"Mutat Res"},{"key":"5385_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s10020-024-00972-y","volume":"30","author":"C Xu","year":"2024","unstructured":"Xu C, Lin W, Zhang Q, Ma Y, Wang X, Guo A, Zhu G, Zhou Z, Song W, Zhao Z, Jiao Y, Wang X, Du C (2024) MGST1 facilitates novel KRAS(G12D) inhibitor resistance in KRAS(G12D)-mutated pancreatic ductal adenocarcinoma by inhibiting ferroptosis. Mol Med 30:199","journal-title":"Mol Med"},{"key":"5385_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03220-9","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Chen Q, Chen D, Yang G (2025a) Role of the TGF-\u03b2\/Smad3 pathway in pancreatic cancer cell growth and stem cell characteristics. Discov Oncol 16","journal-title":"Discov Oncol"},{"key":"5385_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-013269","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Yu R, Li Q, Song S, Fu Y, Shen X, Xu T, Zhang Y, Liang J, Zhang Z, Xu S, Tang J, Zhao Y, Shen C, Zhuang Y, Zhang J, Wang L, Zou X, Chen D, Lv Y, Zhang S (2025b) Epigenetic suppression of Nrf2-Slc40a1 axis induces ferroptosis and enhances immunotherapy in pancreatic cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2025-013269","journal-title":"J Immunother Cancer"},{"key":"5385_CR27","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1097\/MPA.0000000000002426","volume":"54","author":"H Zhao","year":"2025","unstructured":"Zhao H, Huang Q, Liu YA, Wu W (2025) Oncogenic KRAS promotes ferroptosis in pancreatic cancer through regulation of the Fosl1-Tfrc axis. Pancreas 54:e235\u2013e245","journal-title":"Pancreas"},{"key":"5385_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202400829","volume":"63","author":"X Zhao","year":"2024","unstructured":"Zhao X, Wang X, Zhang W, Tian T, Zhang J, Wang J, Wei W, Guo Z, Zhao J, Wang X. A Ferroptosis-Inducing Arsenene-Iridium Nanoplatform for Synergistic Immunotherapy in Pancreatic Cancer. Angew Chem Int Ed Engl. 2024 Apr 8;63(15):e202400829. doi: 10.1002\/anie.202400829. Epub 2024 Feb 28. PMID: 38349715.","journal-title":"Angew Chem Int Ed Engl"},{"key":"5385_CR29","volume":"1879","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Qin C, Lin C, Li Z, Zhao B, Li T, Zhang X, Wang W (2024b) Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: molecular mechanisms and therapeutic targets. Biochimica et Biophysica Acta (BBA) 1879","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"5385_CR30","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1053\/j.gastro.2012.12.042","volume":"144","author":"L Zheng","year":"2013","unstructured":"Zheng L, Xue J, Jaffee EM, Habtezion A (2013) Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma. Gastroenterology 144:1230\u20131240","journal-title":"Gastroenterology"},{"key":"5385_CR31","doi-asserted-by":"publisher","first-page":"D571","DOI":"10.1093\/nar\/gkac935","volume":"51","author":"N Zhou","year":"2022","unstructured":"Zhou N, Yuan X, Du Q, Zhang Z, Shi X, Bao J, Ning Y, Peng L (2022) FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res 51:D571\u2013D582","journal-title":"Nucleic Acids Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05385-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05385-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05385-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:23:39Z","timestamp":1787621019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05385-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5385"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05385-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"1 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}